Portfolio News March 27, 2026 Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Portfolio News February 26, 2026 Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Portfolio News February 26, 2026 Kivu Bioscience Presents KIVU-305 Preclinical Data at World ADC London 2026 and Advances into Phase 1 Clinical Trial – BioSpace
Portfolio News January 15, 2026 First on CNN: Noninvasive brain treatment for depression proves helpful
Portfolio News January 12, 2026 Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors
Portfolio News December 3, 2025 Rondo Therapeutics Doses First Patient in Phase 1 Trial of RNDO-564, a First-in-Class Co-Stimulatory Bispecific Antibody Targeting Nectin-4 in Advanced Solid Tumors
Portfolio News November 24, 2025 Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
Portfolio News October 13, 2025 Excellergy Debuts with $70 Million Series A Financing to Advance First-in-Class Portfolio of Trifunctional Effector Cell Response Inhibitors (ECRIs) for Complete Allergic Control
Portfolio News December 4, 2024 Rondo Therapeutics Announces Collaboration with Lilly to Develop Novel CD28 Bispecific Antibodies for Solid Tumors
Portfolio News September 16, 2024 Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Portfolio News May 1, 2024 MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT® Neuromodulation System to Market
Portfolio News May 1, 2024 Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
Portfolio News March 19, 2024 Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies
Portfolio News December 12, 2023 Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing
Fund News November 16, 2023 Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red Tree Venture Capital as Partner
Fund News November 16, 2023 West Coast investor Red Tree on its San Diego expansion and staying bullish in biotech
Portfolio News April 17, 2023 Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307
Portfolio News March 6, 2023 Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer
Portfolio News March 2, 2023 Ceribell Named to Fast Company’s 2023 List of the World’s Most Innovative Companies
Portfolio News March 1, 2023 CARGO Therapeutics Raises $200 Million in Oversubscribed, Upsized Series A Financing to Advance its Pipeline of Next Generation CAR T-Cell Therapies
Portfolio News March 1, 2023 Tachyon Announces Financing and Start of Clinical Study of First-in-Class KDM4 Inhibitor for Advanced Cancers
Portfolio News September 21, 2022 Ceribell Closes $50 Million Equity Financing Round Led by Ally Bridge Group
Portfolio News September 8, 2022 Ceribell Receives FDA Breakthrough Device Designation for Delirium Indication
Portfolio News September 6, 2022 Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression
Portfolio News July 7, 2022 Magnus Medical Featured on The Today Show – Magnet Therapy Brings Hope to People with Depression
Portfolio News March 2, 2022 Rondo Therapeutics Closes $67 Million Series A Financing to Advance NextGeneration Immuno-Oncology Platform for Solid Tumors
Portfolio News September 28, 2021 Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline
